Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Inventory (2022 - 2025)

Historic Inventory for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to $771686.0.

  • 60 Degrees Pharmaceuticals' Inventory rose 7071.34% to $771686.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $771686.0, marking a year-over-year increase of 7071.34%. This contributed to the annual value of $442764.0 for FY2024, which is 502.07% down from last year.
  • According to the latest figures from Q3 2025, 60 Degrees Pharmaceuticals' Inventory is $771686.0, which was up 7071.34% from $799421.0 recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' 5-year Inventory high stood at $799421.0 for Q2 2025, and its period low was $426020.0 during Q2 2024.
  • Over the past 4 years, 60 Degrees Pharmaceuticals' median Inventory value was $678916.0 (recorded in 2022), while the average stood at $606237.8.
  • As far as peak fluctuations go, 60 Degrees Pharmaceuticals' Inventory tumbled by 4252.42% in 2024, and later surged by 8764.87% in 2025.
  • Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' Inventory stood at $678916.0 in 2022, then plummeted by 31.34% to $466169.0 in 2023, then dropped by 5.02% to $442764.0 in 2024, then skyrocketed by 74.29% to $771686.0 in 2025.
  • Its last three reported values are $771686.0 in Q3 2025, $799421.0 for Q2 2025, and $773238.0 during Q1 2025.